These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 3805529
1. Comparison of programmed stimulation and Holter monitoring for predicting long-term efficacy and inefficacy of amiodarone used alone or in combination with a class 1A antiarrhythmic agent in patients with ventricular tachyarrhythmia. Kim SG, Felder SD, Figura I, Johnston DR, Waspe LE, Fisher JD. J Am Coll Cardiol; 1987 Feb; 9(2):398-404. PubMed ID: 3805529 [Abstract] [Full Text] [Related]
4. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of class IA antiarrhythmic agents in patients with ventricular tachycardia. Kim SG, Seiden SW, Matos JA, Waspe LE, Fisher JD. J Am Coll Cardiol; 1985 Sep; 6(3):539-44. PubMed ID: 2411776 [Abstract] [Full Text] [Related]
9. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of mexiletine in patients with ventricular tachycardia. Kim SG, Seiden SW, Matos JA, Waspe LE, Fisher JD. Am Heart J; 1986 Jul; 112(1):14-9. PubMed ID: 3728269 [Abstract] [Full Text] [Related]
10. The use of ambulatory monitoring in the prognostic evaluation of patients with sustained ventricular tachycardia treated with amiodarone. Veltri EP, Griffith LS, Platia EV, Guarnieri T, Reid PR. Circulation; 1986 Nov; 74(5):1054-60. PubMed ID: 3769165 [Abstract] [Full Text] [Related]
11. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone. Manolis AS, Uricchio F, Estes NA. Am J Cardiol; 1989 May 01; 63(15):1052-7. PubMed ID: 2705375 [Abstract] [Full Text] [Related]
13. Amiodarone in the treatment of life-threatening ventricular tachycardia: role of Holter monitoring in predicting long-term clinical efficacy. Veltri EP, Reid PR, Platia EV, Griffith LS. J Am Coll Cardiol; 1985 Oct 01; 6(4):806-13. PubMed ID: 3928726 [Abstract] [Full Text] [Related]
14. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy. Rae AP, Spielman SR, Kutalek SP, Kay HR, Horowitz LN. Am J Cardiol; 1987 Feb 01; 59(4):291-5. PubMed ID: 3544793 [Abstract] [Full Text] [Related]
16. Invasive and noninvasive methods to predict the long-term efficacy of amiodarone: a compilation of clinical observations using meta-analysis. Roberts SA, Viana MA, Nazari J, Bauman JL. Pacing Clin Electrophysiol; 1994 Oct 01; 17(10):1590-602. PubMed ID: 7800560 [Abstract] [Full Text] [Related]
17. Reappraisal of criteria for assessing drug efficacy in patients with ventricular tachyarrhythmias: complete versus partial suppression of inducible arrhythmias. Borggrefe M, Trampisch HJ, Breithardt G. J Am Coll Cardiol; 1988 Jul 01; 12(1):140-9. PubMed ID: 3379199 [Abstract] [Full Text] [Related]
18. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study. Klein LS, Fineberg N, Heger JJ, Miles WM, Kammerling JM, Chang MS, Zipes DP, Prystowsky EN. Am J Cardiol; 1988 May 01; 61(13):1024-30. PubMed ID: 3364357 [Abstract] [Full Text] [Related]